Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.

We undertook a prospective, randomized, non-blinded pilot study to determine whether infants with respiratory distress syndrome (RDS) who were treated with protein-containing bovine surfactant (Survanta, Ross/Abbott Laboratories, Columbus, Ohio) had earlier and larger responses in gas exchange when...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sehgal, S. S., Ewing, C. K., Richards, T., Taeusch, H. W.
Médium: Artigo
Jazyk:Inglês
Vydáno: National Medical Association 1994
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2607653/
https://ncbi.nlm.nih.gov/pubmed/8151722
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky